Arkolith/Insider Trading/RARE/Form 4

Parschauer Karah Herdman

EVP and Chief Legal OfficerUltragenyx Pharmaceutical Inc. (RARE) · full profile →Form 4 · filed Jun 15, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$47K
Net Open-Market Flow
-$47K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 15, 2026Sell(S)2K$24.62$47K94K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001677455-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML